Lincoln Pharmaceuticals Limited

Informe acción NSEI:LINCOLN

Capitalización de mercado: ₹11.4b

Dividendos de Lincoln Pharmaceuticals

Dividendo controles de criterios 4/6

Lincoln Pharmaceuticals es una empresa que paga dividendos con una rentabilidad actual de 0.25% que está bien cubierta por los beneficios.

Información clave

0.3%

Rentabilidad por dividendo

4%

Ratio de pago

Rentabilidad media de la industria0.8%
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acciónn/a
Beneficios por acción₹43.57
Rentabilidad por dividendo prevista a 3 añosn/a

Últimas actualizaciones de dividendos

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 12
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Recent updates

Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Mar 14
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Nov 04
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 12
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

Aug 29
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Aug 16
Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

May 06
Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Apr 03
Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Mar 15
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Feb 28
Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Feb 12
Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Feb 01
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Jan 19
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Jan 06
Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Dec 27
Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Dec 14
Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Dec 01
Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Nov 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Nov 05
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?

Oct 23
Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year

Oct 05
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year

Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why

Sep 18
Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why

Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares

Aug 31
Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares

Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price

Aug 21
Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: Los dividendos por acción de LINCOLN se han mantenido estables en los últimos 10 años.

Dividendo creciente: El pago de dividendos de LINCOLN ha aumentado en los últimos 10 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Lincoln Pharmaceuticals vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de LINCOLN con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (LINCOLN)0.3%
Suelo de mercado 25% (IN)0.3%
Techo de mercado 25% (IN)1.2%
Media de la industria (Pharmaceuticals)0.8%
Previsión de analistas en 3 años (LINCOLN)n/a

Dividendo destacado: El dividendo de LINCOLN(0.26%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado Indian (0.27%).

Alto dividendo: El (0.25%) del dividendo de LINCOLN es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Indian (1.22%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su bajo ratio de pago (3.7%), los pagos de dividendos de LINCOLN están totalmente cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su bajo ratio de pago en efectivo (4.5%), los pagos de dividendos de LINCOLN están totalmente cubiertos por los flujos de caja.


Discover strong dividend paying companies